Greenwich Lifesciences Inc宣布,其商业化生产的Gp2已获得在欧洲用于Flamingo-01研究的批准。这一进展标志着该公司在推进其核心候选产品方面取得了重要的监管里程碑。
Greenwich Lifesciences Inc宣布,其商业化生产的Gp2已获得在欧洲用于Flamingo-01研究的批准。这一进展标志着该公司在推进其核心候选产品方面取得了重要的监管里程碑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.